Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Medtronic
Colorcon
Express Scripts
Moodys

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MINIRIN

➤ Subscribe for complete access

« Back to Dashboard

All Clinical Trials for Minirin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00209261 ↗ A 6-week Open Label Cross-over Study With 2 Different Daily Doses of MinirinĀ® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE) Completed Ferring Pharmaceuticals Phase 4 2004-12-01 To evaluate the preference of subjects for MinirinĀ® oral lyophilisate treatment compared with MinirinĀ® tablet treatment after 6 weeks. To compare efficacy of the 2 formulations at the end of the 6-week treatment period using diary card data. To compare ease of use of both formulations at 3 and 6 weeks using a VAS-scale. To validate a PNE Quality of Life (QoL) questionnaire. To evaluate safety. To compare compliance with the 2 formulations
NCT00592566 ↗ Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis Terminated Thailand Research Fund Phase 2/Phase 3 2003-07-01 Background: Pulmonary involvement in leptospirosis has been reported to be on the increase and is emerging as the main cause of death due to leptospirosis in many countries, including Thailand. Methods: A prospective randomized controlled trial of desmopressin or high dose dexamethasone as adjunctive therapy in patients with suspected pulmonary hemorrhage associated with leptospirosis was conducted between July 2003 and October 2006 at 5 hospitals in Thailand.
NCT00592566 ↗ Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis Terminated Mahidol University Phase 2/Phase 3 2003-07-01 Background: Pulmonary involvement in leptospirosis has been reported to be on the increase and is emerging as the main cause of death due to leptospirosis in many countries, including Thailand. Methods: A prospective randomized controlled trial of desmopressin or high dose dexamethasone as adjunctive therapy in patients with suspected pulmonary hemorrhage associated with leptospirosis was conducted between July 2003 and October 2006 at 5 hospitals in Thailand.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Minirin

Condition Name

Condition Name for Minirin
Intervention Trials
Nocturia 5
Nocturnal Enuresis 4
Obstructive Sleep Apnoea 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Minirin
Intervention Trials
Nocturnal Enuresis 6
Enuresis 6
Nocturia 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Minirin

Trials by Country

Trials by Country for Minirin
Location Trials
Japan 26
Korea, Republic of 1
Hong Kong 1
Iran, Islamic Republic of 1
Egypt 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Minirin

Clinical Trial Phase

Clinical Trial Phase for Minirin
Clinical Trial Phase Trials
Phase 4 4
Phase 3 4
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Minirin
Clinical Trial Phase Trials
Completed 10
Terminated 2
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Minirin

Sponsor Name

Sponsor Name for Minirin
Sponsor Trials
Ferring Pharmaceuticals 6
Samsung Medical Center 1
University Hospital, Ghent 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Minirin
Sponsor Trials
Other 10
Industry 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Express Scripts
Merck
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.